Alterity Therapeutics ATHE
NASDAQ ATHE
$2.31 -0.01 (-0.43%)
At close: Nov 11, 2026 · 4:00 PM EST

Alterity Therapeutics (ATHE) Income After Tax (2016 - 2018)

Updated

Alterity Therapeutics (ATHE) reported Profit After Tax of -$16.44 trillion for the year ended Jun 30, 2026, compared with -$7.74 trillion a year earlier.

Analysis

Alterity Therapeutics (ATHE) Income After Tax (2016 - 2018) Analysis & Trends

Dating back to the year ended Jun 30, 2009, Alterity Therapeutics' Profit After Tax record includes 18 years.

  • The figure for the year ended Jun 30, 2026 ranks as the lowest annual Profit After Tax in data going back to the year ended Jun 30, 2009.
  • According to Business Quant data, Profit After Tax came in at -$7.74 trillion in the year ended Jun 30, 2025, -$190,313 in the year ended Aug 29, 2024, -$135,976 in the year ended Dec 31, 2023 and -$9.1 trillion in the year ended Jun 30, 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income After Tax (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 6.45 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 210.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 4.22 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 5.07 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 4.80 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 3.86 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 2.43 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 3.25 Bn
10 Alterity Therapeutics 42.05 Mn -41.10 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 -3.83 Mn
Dec 31, 2017 -2.78 Mn
Dec 31, 2016 -2.74 Mn
API Access

Alterity Therapeutics Income After Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=profit-after-tax&ticker=ATHE&period=max&api_key=YOUR_API_KEY